NCT02391662 - Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 23, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions

Pancreatic Carcinoma Metastatic

Interventions

DRUG

Nab-paclitaxel 125 mg/m2 weeks 1,2,3/4

Nab-paclitaxel 125 mg/m2 days 1,8 \& 15 in a 28 days cycle

DRUG

Gemcitabine 1000 weeks 1,2,3/4

Gemcitabine 1000 days 1,8 \& 15 in a 28 days cycle

Trial Locations (21)

17007

Ico Girona, Girona

23007

Complejo Hospitalario de Jaén, Jaén

27003

Hospital Universitario Lucus Augusti, Lugo

28006

Hospital Universitario de La Princesa, Madrid

28046

Hospital Universitario La Paz, Madrid

28050

Hospital Universitario Hm Sanchinarro, Madrid

28223

Hospital Quirón Madrid, Madrid

30120

Hospital Clinico Universitario Virgen de La Arrixaca, El Palmar

32005

Complexo Hospitalario Universitario de Ourense, Ourense

35016

C. Hospitalario Universitario Insularmaterno-Infantil, Las Palmas de Gran Canaria

36204

Hospital Xeral de Vigo, Vigo

38320

Complejo Hospitalario Universitario de Canarias, San Cristóbal de La Laguna

41009

Complejo Hospitalario Regional Virgen Macarena, Seville

41013

Hospital Virgen Del Rocio, Seville

48903

Hospital Universitario de Cruces, Barakaldo

08402

Hospital General de Granollers, Granollers

08240

Centre Hospitalari de Manresa, Manresa

03010

Hospital General Universitario de Alicante, Alicante

06080

Hospital Infanta Cristina, Badajoz

08035

Hospital Universitario Vall D'Hebron, Barcelona

09006

Hospital Universitario de Burgos, Burgos